From: Time interval between alfentanil and rocuronium administration necessary to prevent rocuronium-induced withdrawal movement
Characteristics
Male
Female
Number of patients(n)
33
31
Age (year)
44.5 ± 14.6
41.8 ± 9.3
Weight (kg)
66.1 ± 8.1
58.4 ± 6.0*
Height (cm)
170.6 ± 5.2
158.2 ± 3.8*
BMI (kg/m2)
22.7 ± 2.4
23.3 ± 2.2
ASA physical status(I/II)
12/21
9/22